Israel’s Oncohost (reported here previously) presented the results of its latest proteomic (proteins) cancer study to the Society for Immunotherapy of Cancer’s (SITC). Oncohost’s PROphet host response profiling platform can predict the best therapy to use for specific cancer patients.
https://jewishbusinessnews.com/2020/11/15/oncohost-offers-new-hope-for-pancreatic-cancer-sufferers/
https://www.sitcancer.org/2020/program/annual-meeting-schedule-2020#tab6